| Q4 2021 |
|
|
|
|
|
|
13F-NT |
2/11/2022, 09:46 AM |
| Q3 2021 |
|
|
|
|
|
|
13F-NT |
11/12/2021, 01:42 PM |
| Q2 2021 |
|
|
|
|
|
|
13F-NT |
8/16/2021, 07:00 AM |
| Q1 2021 |
|
|
|
|
|
|
13F-NT |
5/14/2021, 06:15 AM |
| Q4 2020 |
|
|
|
|
|
|
13F-NT |
2/16/2021, 06:00 AM |
| Q3 2020 |
149 |
$2.17B |
+$234M |
-$191M |
+$43M |
GSKXXXX, BMY, ORCL, JPM, C
|
13F-HR |
11/16/2020, 05:15 AM |
| Q2 2020 |
154 |
$2.31B |
+$193M |
-$520M |
-$328M |
FE, GSKXXXX, BMY, ORCL, C
|
13F-HR |
8/14/2020, 07:30 AM |
| Q1 2020 |
149 |
$2.28B |
+$416M |
-$311M |
+$105M |
FE, GSKXXXX, BMY, ORCL, JPM
|
13F-HR |
5/14/2020, 09:00 AM |
| Q4 2019 |
160 |
$4.02B |
+$465M |
-$583M |
-$118M |
C, FE, GSKXXXX, JPM, RNR
|
13F-HR |
2/14/2020, 05:20 AM |
| Q3 2019 |
155 |
$4.13B |
+$373M |
-$573M |
-$200M |
RNR, FE, C, ETRN, GSKXXXX
|
Restatement |
2/13/2020, 03:49 PM |
| Q2 2019 |
144 |
$4.2B |
+$290M |
-$347M |
-$57M |
RNR, ETRN, FE, MLNX, JPM
|
13F-HR |
8/14/2019, 08:01 AM |
| Q1 2019 |
145 |
$4.48B |
+$443M |
-$415M |
+$27.2M |
RNR, FE, ETRN, C, CIT
|
13F-HR |
5/14/2019, 10:19 AM |
| Q4 2018 |
147 |
$4.2B |
+$523M |
-$229M |
+$294M |
RNR, FE, ORCL, C, CIT
|
13F-HR |
2/14/2019, 07:47 AM |
| Q3 2018 |
145 |
$4.68B |
+$455M |
-$354M |
+$101M |
CIT, C, FE, ORCL, JPM
|
13F-HR |
11/14/2018, 02:31 PM |
| Q2 2018 |
160 |
$5.53B |
+$417M |
-$1.04B |
-$619M |
EQT, CIT, CRZO, C, ORCL
|
13F-HR |
8/14/2018, 01:31 PM |
| Q1 2018 |
175 |
$6.19B |
+$472M |
-$1.49B |
-$1.02B |
CIT, ORCL, EQT, JPM, C
|
13F-HR |
5/14/2018, 03:58 PM |
| Q4 2017 |
197 |
$7.7B |
+$698M |
-$769M |
-$71M |
CIT, EQT, ORCL, C, JPM
|
13F-HR |
2/14/2018, 04:10 PM |
| Q3 2017 |
194 |
$8.17B |
+$1.14B |
-$991M |
+$148M |
CIT, ORCL, C, JPM, CRZO
|
13F-HR |
11/14/2017, 06:00 AM |
| Q2 2017 |
194 |
$7.23B |
+$624M |
-$579M |
+$45.2M |
CIT, ORCL, C, JPM, EQT
|
13F-HR |
8/14/2017, 01:17 PM |
| Q1 2017 |
188 |
$7.59B |
+$732M |
-$613M |
+$119M |
CIT, ORCL, C, JPM, UNM
|
13F-HR |
5/15/2017, 01:10 PM |
| Q4 2016 |
208 |
$7.35B |
+$990M |
-$984M |
+$5.88M |
CIT, C, ORCL, UNM, JPM
|
13F-HR |
2/14/2017, 03:23 PM |
| Q3 2016 |
192 |
$6.88B |
+$1.42B |
-$423M |
+$993M |
UNM, C, ORCL, CIT, JPM
|
13F-HR |
11/14/2016, 02:19 PM |
| Q2 2016 |
150 |
$5.82B |
+$440M |
-$803M |
-$364M |
UNM, ORCL, C, AONXXXX, EQT
|
13F-HR |
8/12/2016, 02:23 PM |
| Q1 2016 |
144 |
$6.41B |
+$526M |
-$384M |
+$141M |
UNM, ORCL, C, AONXXXX, CIT
|
13F-HR |
5/12/2016, 01:28 PM |
| Q4 2015 |
151 |
$6.46B |
+$460M |
-$536M |
-$76M |
C, UNM, CIT, ORCL, TER
|
13F-HR |
2/12/2016, 11:39 AM |
| Q3 2015 |
156 |
$6.49B |
+$491M |
-$375M |
+$116M |
C, UNM, PFE, TEVA, JPM
|
13F-HR |
11/16/2015, 12:58 PM |
| Q2 2015 |
147 |
$7.23B |
+$593M |
-$857M |
-$264M |
C, UNM, TEVA, JPM, PFE
|
13F-HR |
8/14/2015, 09:36 AM |
| Q1 2015 |
155 |
$8.02B |
+$1.03B |
-$838M |
+$191M |
TEVA, C, PFE, UNM, SNY
|
13F-HR |
5/14/2015, 03:07 PM |
| Q4 2014 |
172 |
$8.33B |
+$916M |
-$1.36B |
-$441M |
TEVA, C, UNM, PFE, MSFT
|
13F-HR |
2/13/2015, 02:02 PM |
| Q3 2014 |
177 |
$9.05B |
+$947M |
-$1.21B |
-$261M |
C, TEVA, APAXXXX, MSFT, UNM
|
13F-HR |
11/14/2014, 12:02 PM |
| Q2 2014 |
177 |
$9.94B |
+$748M |
-$2.29B |
-$1.54B |
AIG, C, HIG, TEVA, APAXXXX
|
Restatement |
8/14/2014, 04:32 PM |
| Q1 2014 |
164 |
$11.4B |
+$945M |
-$909M |
+$35.4M |
HIG, AIG, C, TEVA, MSFT
|
13F-HR |
5/14/2014, 10:33 AM |
| Q4 2013 |
163 |
$11.4B |
|
|
|
HIG, AIG, C, GM, MSFT
|
13F-HR |
2/14/2014, 01:17 PM |